選擇晚期非小細胞肺癌第一線ALK標靶藥物Alectinib之相關因素探討

Translated title of the contribution: Factors Associated with Selection of First-Line Alectinib in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer
  • 田嘉惠

Research output: Types of ThesisMaster's thesis

Translated title of the contributionFactors Associated with Selection of First-Line Alectinib in Patients with Advanced ALK-Positive Non-Small Cell Lung Cancer
Original languageChinese (Traditional)
Supervisors/Advisors
  • Cheng, Jur-Shan, Supervisor
StatePublished - 2025
Externally publishedYes

Cite this